Position in ACB
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2
-$3 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#141
of 149 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Providence Capital Advisors, LLC holds $15,756 across 4 Drug Manufacturers - Specialty & Generic names. ACB ranks #4 (0.0% of the industry book) .
All Filings in ACB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2 | 1 | Shares | Sole | 2026-08-11 | |
| 2024-09-30 | $5 | 1 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4 | 1 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4 | 1 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5 | 12 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7 | 12 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6 | 12 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $8 | 12 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $18 | 20 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $24 | 20 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $26 | 20 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $80 | 20 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $108 | 20 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $138 | 20 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $180 | 20 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $186 | 20 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $166 | 20 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $93 | 20 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $248 | 20 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $226 | 250 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||